Abstract
For long time, the heart was categorized as a post-mitotic organ, unable to undergo substantial renewal during the adult life. The heart scenario was opposite to the situation of other organs such as the liver, the skin and the bone marrow, whose ability to regenerate has been known for longtime. Today, several proofs exist that the heart has a self renewal capacity similar to that in other organs due to the discovery of resident stem cells that have been shown to produce new myocytes throughout the adult life. If the discovery of stem cells in the heart has resolved the issue of myocardial renewal, it has not resolved yet the issue of the best “biological treatment” to efficiently repair myocardium after ischemic damage. In fact, up to date, no clear indication exists about the identity of progenitor cells that are best suited as “biological drugs” for myocardial repair. In addition, despite the always growing number of publications describing the ability of cardiac and non-cardiac derived cells to repair the ischemic heart in preclinical models, the limited, although remarkable, clinical benefits obtained in first generation clinical trials in patients, have raised the issue of stem cell-mediated cardiac repair efficiency. In this contribution, the present and the future of heart repair will be outlined in the view of the most recent advancements in the understanding of basic biology, preclinical testing and clinical translation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdel-Latif A, Bolli R, Tleyjeh I M et al (2007) Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167: 989–97.
Amsalem Y, Mardor Y, Feinberg M S et al (2007) Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 116: I38–45.
Andersen D C, Andersen P, Schneider M et al (2009) Murine “cardiospheres” are not a source of stem cells with cardiomyogenic potential. Stem Cells 27: 1571–81.
Anversa P, Kajstura J, Leri A et al (2006) Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation 113: 1451–63.
Anversa P, Palackal T, Sonnenblick E H et al (1990) Hypertensive cardiomyopathy. Myocyte nuclei hyperplasia in the mammalian rat heart. J Clin Invest 85: 994–7.
Astorri E, Bolognesi R, Colla B et al (1977) Left ventricular hypertrophy: a cytometric study on 42 human hearts. J Mol Cell Cardiol 9: 763–75.
Ayach B B, Yoshimitsu M, Dawood F et al (2006) Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction. Proc Natl Acad Sci USA 103: 2304–9.
Barile L, Chimenti I, Gaetani R et al (2007) Cardiac stem cells: isolation, expansion and experimental use for myocardial regeneration. Nat Clin Pract Cardiovasc Med 4 Suppl 1: S9–S14.
Bearzi C, Leri A, Lo Monaco F et al (2009) Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci USA 106:14022–7.
Bearzi C, Rota M, Hosoda T et al (2007) Human cardiac stem cells. Proc Natl Acad Sci USA 104: 14068–73.
Beltrami A P, Barlucchi L, Torella D et al (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763–76.
Beltrami A P, Urbanek K, Kajstura J et al (2001) Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344: 1750–7.
Beltrami C A, Di Loreto C, Finato N et al (1997) Proliferating cell nuclear antigen (PCNA), DNA synthesis and mitosis in myocytes following cardiac transplantation in man. J Mol Cell Cardiol 29: 2789–802.
Bergmann O, Bhardwaj R D, Bernard S et al (2009) Evidence for cardiomyocyte renewal in humans. Science 324: 98–102.
Besmer P (1991) The kit ligand encoded at the murine Steel locus: a pleiotropic growth and differentiation factor. Curr Opin Cell Biol 3: 939–46.
Besmer P, Manova K, Duttlinger R et al (1993) The kit-ligand (steel factor) and its receptor c-kit/W: pleiotropic roles in gametogenesis and melanogenesis. Dev Suppl: 125–37.
Boheler K R (2009) Stem cell pluripotency: a cellular trait that depends on transcription factors, chromatin state and a checkpoint deficient cell cycle. J Cell Physiol 221: 10–7.
Boni A, Urbanek K, Nascimbene A et al (2008) Notch1 regulates the fate of cardiac progenitor cells. Proc Natl Acad Sci USA 105: 15529–34.
Borchardt T and Braun T (2007) Cardiovascular regeneration in non-mammalian model systems: what are the differences between newts and man? Thromb Haemost 98: 311–8.
Bu L, Jiang X, Martin-Puig S et al (2009) Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 460: 113–7.
Buckingham M, Meilhac S and Zaffran S (2005) Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet 6: 826–35.
Cai C L, Liang X, Shi Y et al (2003) Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 5: 877–89.
Capogrossi M C (2004) Cardiac stem cells fail with aging: a new mechanism for the age-dependent decline in cardiac function. Circ Res 94: 411–3.
Challen G A and Little M H (2006) A side order of stem cells: the SP phenotype. Stem Cells 24: 3–12.
Chen V C, Stull R, Joo D et al (2008) Notch signaling respecifies the hemangioblast to a cardiac fate. Nat Biotechnol 26: 1169–78.
Chimenti C, Kajstura J, Torella D et al (2003) Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res 93: 604–13.
Cho H J, Lee N, Lee J Y et al (2007) Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J Exp Med 204: 3257–69.
Christoffels V M, Grieskamp T, Norden J et al (2009) Tbx18 and the fate of epicardial progenitors. Nature 458: E8–9; discussion E9–10.
Christoforou N, Miller R A, Hill C M et al (2008) Mouse ES cell-derived cardiac precursor cells are multipotent and facilitate identification of novel cardiac genes. J Clin Invest 118: 894–903.
Cohen E D, Tian Y and Morrisey E E (2008) Wnt signaling: an essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development 135: 789–98.
Collesi C, Zentilin L, Sinagra G et al (2008) Notch1 signaling stimulates proliferation of immature cardiomyocytes. J Cell Biol 183: 117–28.
Davis D R, Zhang Y, Smith R R et al (2009) Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS One 4: e7195.
De Falco E, Avitabile D, Totta P et al (2009) Altered Sdf-1-Mediated Diffferentiation of Bone Marrow-Derived Endothelial Progenitor Cells in Diabetes Mellitus. J Cell Mol Med [Epub ahead of print].
Dernbach E, Urbich C, Brandes R P et al (2004) Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood 104: 3591–7.
Di Stefano V, Cencioni C, Zaccagnini G et al (2009) p66ShcA modulates oxidative stress and survival of endothelial progenitor cells in response to high glucose. Cardiovasc Res 82: 421–9.
Dimmeler S, Aicher A, Vasa M et al (2001) HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108: 391–7.
Fazel S, Cimini M, Chen L et al (2006) Cardioprotective c-kit + cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 116: 1865–77.
Flaherty M P, Abdel-Latif A, Li Q et al (2008) Noncanonical Wnt11 signaling is sufficient to induce cardiomyogenic differentiation in unfractionated bone marrow mononuclear cells. Circulation 117: 2241–52.
Flaherty M P and Dawn B (2008) Noncanonical Wnt11 signaling and cardiomyogenic differentiation. Trends Cardiovasc Med 18: 260–8.
Freund C and Mummery C L (2009) Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models. J Cell Biochem 107: 592–9.
Gaipa G, Tilenni M, Straino S et al (2010) GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy. J Cell Mol Med 14(6B): 1619–34.
Gianella A, Guerrini U, Tilenni M et al (2010) Magnetic Resonance Imaging of Human Endothelial Progenitors Reveals Opposite Effects on Vascular and Muscle Regeneration into Ischemic Tissues. Cardiovasc Res 85: 503–13.
Gude N A, Emmanuel G, Wu W et al (2008) Activation of Notch-mediated protective signaling in the myocardium. Circ Res 102: 1025–35.
Hiasa K I, Ishibashi M, Ohtani K et al (2004) Gene Transfer of Stromal Cell-Derived Factor-1{alpha} Enhances Ischemic Vasculogenesis and Angiogenesis via Vascular Endothelial Growth Factor/Endothelial Nitric Oxide Synthase-Related Pathway. Next-Generation Chemokine Therapy for Therapeutic Neovascularization. Circulation 17: 17.
Hierlihy A M, Seale P, Lobe C G et al (2002) The post-natal heart contains a myocardial stem cell population. FEBS Lett 530: 239–43.
Hill J M, Zalos G, Halcox J P et al (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593–600.
Holmes C and Stanford W L (2007) Concise review: stem cell antigen-1: expression, function, and enigma. Stem Cells 25: 1339–47.
Hosoda T, D’Amario D, Cabral-Da-Silva M C et al (2009) Clonality of mouse and human cardiomyogenesis in vivo. Proc Natl Acad Sci USA 106: 17169–74.
Huang E, Nocka K, Beier D R et al (1990) The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 63: 225–33.
Hur J, Yang H M, Yoon C H et al (2007) Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies. Circulation 116: 1671–82.
Itzhaki-Alfia A, Leor J, Raanani E et al (2009) Patient characteristics and cell source determine the number of isolated human cardiac progenitor cells. Circulation 120: 2559–66.
Joggerst S J and Hatzopoulos A K (2009) Stem cell therapy for cardiac repair: benefits and barriers. Expert Rev Mol Med 11: e20.
Johnston P V, Sasano T, Mills K et al (2009) Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation 120: 1075–83, 7 p following 1083.
Kajstura J, Leri A, Finato N et al (1998) Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 95: 8801–5.
Kajstura J, Rota M, Whang B et al (2005) Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 96: 127–37.
Kamp T J and Lyons G E (2009) On the road to iPS cell cardiovascular applications. Circ Res 105: 617–9.
Kang S, Yang Y J, Li C J et al (2008) Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials. Coron Artery Dis 19: 327–35.
Krankel N, Adams V, Linke A et al (2005) Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler Thromb Vasc Biol 25: 698–703.
Kuzmenkin A, Liang H, Xu G et al (2009) Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro. Faseb J 23: 4168–80.
Kwon C, Arnold J, Hsiao E C et al (2007) Canonical Wnt signaling is a positive regulator of mammalian cardiac progenitors. Proc Natl Acad Sci USA 104: 10894–9.
Kwon C, Qian L, Cheng P et al (2009) A regulatory pathway involving Notch1/beta-catenin/Isl1 determines cardiac progenitor cell fate. Nat Cell Biol 11: 951–7.
Laugwitz K L, Moretti A, Lam J et al (2005) Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433: 647–53.
Leri A, Barlucchi L, Limana F et al (2001) Telomerase expression and activity are coupled with myocyte proliferation and preservation of telomeric length in the failing heart. Proc Natl Acad Sci USA 98: 8626–31.
Li M, Naqvi N, Yahiro E et al (2008) c-kit is required for cardiomyocyte terminal differentiation. Circ Res 102: 677–85.
Limana F, Bertolami C, Mangoni A et al (2009) Myocardial infarction induces embryonic reprogramming of epicardial c-kit(+) cells: Role of the pericardial fluid. J Mol Cell Cardiol.
Limana F, Zacheo A, Mocini D et al (2007) Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circ Res 101: 1255–65.
Linzbach A J (1960) Heart failure from the point of view of quantitative anatomy. Am J Cardiol 5: 370–82.
Lipinski M J, Biondi-Zoccai G G, Abbate A et al (2007) Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 50: 1761–7.
Loomans C J, De Koning E J, Staal F J et al (2005) Endothelial progenitor cell dysfunction in type 1 diabetes: another consequence of oxidative stress? Antioxid Redox Signal 7: 1468–75.
Loomans C J, de Koning E J, Staal F J et al (2004) Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53: 195–9.
Madeddu P, Kraenkel N, Barcelos L S et al (2008) Phosphoinositide 3-kinase gamma gene knockout impairs postischemic neovascularization and endothelial progenitor cell functions. Arterioscler Thromb Vasc Biol 28: 68–76.
Mangi A A, Noiseux N, Kong D et al (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9: 1195–201.
Marchetti V, Menghini R, Rizza S et al (2006) Benfotiamine Counteracts Glucose Toxicity Effects on Endothelial Progenitor Cell Differentiation via Akt/FoxO Signaling. Diabetes 55: 2231–7.
Martinez-Fernandez A, Nelson T J, Yamada S et al (2009) iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Circ Res 105: 648–56.
Martin-Rendon E, Brunskill S, Doree C et al (2008a) Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev: CD006536.
Martin-Rendon E, Brunskill S J, Hyde C J et al (2008b) Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 29: 1807–18.
Matsuura K, Honda A, Nagai T et al (2009) Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest 119: 2204–17.
Matsuura K, Nagai T, Nishigaki N et al (2004) Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 279: 11384–91.
Mauritz C, Schwanke K, Reppel M et al (2008) Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118: 507–17.
Meilhac S M, Esner M, Kelly R G et al (2004) The clonal origin of myocardial cells in different regions of the embryonic mouse heart. Dev Cell 6: 685–98.
Meissner A, Mikkelsen T S, Gu H et al (2008) Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454: 766–70.
Messina E, De Angelis L, Frati G et al (2004) Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95: 911–21.
Mikkelsen T S, Hanna J, Zhang X et al (2008) Dissecting direct reprogramming through integrative genomic analysis. Nature 454: 49–55.
Mikkelsen T S, Ku M, Jaffe D B et al (2007) Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448: 553–60.
Moretti A, Bellin M, Jung C B et al (2009) Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors. Faseb J.
Moretti A, Caron L, Nakano A et al (2006) Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127: 1151–65.
Muraski J A, Rota M, Misao Y et al (2007) Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat Med 13: 1467–75.
Nelson T J, Martinez-Fernandez A, Yamada S et al (2009) Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120: 408–16.
Neumuller R A and Knoblich J A (2009) Dividing cellular asymmetry: asymmetric cell division and its implications for stem cells and cancer. Genes Dev 23: 2675–99.
Oh H, Bradfute S B, Gallardo T D et al (2003) Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 100: 12313–8.
Orlic D, Kajstura J, Chimenti S et al (2001a) Bone marrow cells regenerate infarcted myocardium. Nature 410: 701–5.
Orlic D, Kajstura J, Chimenti S et al (2001b) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 98: 10344–9.
Pandur P, Lasche M, Eisenberg L M et al (2002) Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 418: 636–41.
Pesce M, Farrace M G, Piacentini M et al (1993) Stem cell factor and leukemia inhibitory factor promote primordial germ cell survival by suppressing programmed cell death (apoptosis). Development 118: 1089–94.
Quaini F, Urbanek K, Beltrami A P et al (2002) Chimerism of the transplanted heart. N Engl J Med 346: 5–15.
Rehman J, Li J, Orschell C M et al (2003) Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164–9.
Rohde E, Bartmann C, Schallmoser K et al (2007) Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Stem Cells 25: 1746–52.
Rohde E, Malischnik C, Thaler D et al (2006) Blood monocytes mimic endothelial progenitor cells. Stem Cells 24: 357–67.
Romagnani P, Annunziato F, Liotta F et al (2005) CD14 + CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 97: 314–22.
Rota M, LeCapitaine N, Hosoda T et al (2006) Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res 99: 42–52.
Scheper W and Copray S (2009) The molecular mechanism of induced pluripotency: a two-stage switch. Stem Cell Rev Rep 5: 204–23.
Seeger F H, Tonn T, Krzossok N et al (2007a) Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J 28: 766–72.
Seeger F H, Zeiher A M and Dimmeler S (2007b) Cell-enhancement strategies for the treatment of ischemic heart disease. Nat Clin Pract Cardiovasc Med 4 Suppl 1: S110–3.
Shenje L T, Field L J, Pritchard C A et al (2008) Lineage tracing of cardiac explant derived cells. PLoS One 3: e1929.
Smith R R, Barile L, Cho H C et al (2007) Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115: 896–908.
Smits A M, van den Hengel L G, van den Brink S et al (2009a) A new in vitro model for stem cell differentiation and interaction. Stem Cell Res 2: 108–12.
Smits A M, van Laake L W, den Ouden K et al (2009b) Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc Res 83: 527–35.
Smits A M, van Vliet P, Metz C H et al (2009c) Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology. Nat Protoc 4: 232–43.
Sussman M A and Anversa P (2004) Myocardial aging and senescence: where have the stem cells gone? Annu Rev Physiol 66: 29–48.
Tajbakhsh S, Rocheteau P and Le Roux I (2009) Asymmetric cell divisions and asymmetric cell fates. Annu Rev Cell Dev Biol 25: 671–99.
Takahashi K and Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663–76.
Tallini Y N, Greene K S, Craven M et al (2009) c-kit expression identifies cardiovascular precursors in the neonatal heart. Proc Natl Acad Sci USA 106: 1808–13.
Tateishi K, Ashihara E, Honsho S et al (2007) Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt/GSK-3beta signaling. Biochem Biophys Res Commun 352: 635–41.
Thum T, Bauersachs J, Poole-Wilson P A et al (2005) The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol 46: 1799–802.
Tillmanns J, Rota M, Hosoda T et al (2008) Formation of large coronary arteries by cardiac progenitor cells. Proc Natl Acad Sci USA 105: 1668–73.
Torella D, Rota M, Nurzynska D et al (2004) Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res 94: 514–24.
Urbanek K, Cesselli D, Rota M et al (2006) Stem cell niches in the adult mouse heart. Proc Natl Acad Sci USA 103: 9226–31.
Urbanek K, Torella D, Sheikh F et al (2005) Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci USA 102: 8692–7.
Urbich C and Dimmeler S (2005) Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int 67: 1672–6.
Urbich C, Heeschen C, Aicher A et al (2003) Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108: 2511–6. Epub 2003 Oct 27.
Urbich C, Knau A, Fichtlscherer S et al (2005) FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells. Faseb J 19: 974–6.
Vasa M, Fichtlscherer S, Aicher A et al (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1–7.
Wandzioch E, Edling C E, Palmer R H et al (2004) Activation of the MAP kinase pathway by c-Kit is PI-3 kinase dependent in hematopoietic progenitor/stem cell lines. Blood 104: 51–7.
Wilmut I, Schnieke A E, McWhir J et al (1997) Viable offspring derived from fetal and adult mammalian cells. Nature 385: 810–3.
Wu M T, Su M Y, Huang Y L et al (2009) Sequential changes of myocardial microstructure in patients postmyocardial infarction by diffusion-tensor cardiac MR: correlation with left ventricular structure and function. Circ Cardiovasc Imaging 2: 32–40, 6 p following 40.
Wu S M, Fujiwara Y, Cibulsky S M et al (2006) Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 127: 1137–50.
Yang L, Soonpaa M H, Adler E D et al (2008) Human cardiovascular progenitor cells develop from a KDR + embryonic-stem-cell-derived population. Nature 453: 524–8.
Yoon C H, Hur J, Park K W et al (2005) Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 112: 1618–27.
Zelarayan L C, Noack C, Sekkali B et al (2008) Beta-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation. Proc Natl Acad Sci USA 105: 19762–7.
Zhang J, Wilson G F, Soerens A G et al (2009a) Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104: e30–41.
Zhang Y, Ingram D A, Murphy M P et al (2009b) Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells. Am J Physiol Heart Circ Physiol 296: H1675–82.
Zheng H, Dai T, Zhou B et al (2008) SDF-1alpha/CXCR4 decreases endothelial progenitor cells apoptosis under serum deprivation by PI3K/Akt/eNOS pathway. Atherosclerosis.201(1):36–42
Zheng H, Fu G, Dai T et al (2007) Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol 50: 274–80.
Zhou B, Ma Q, Rajagopal S et al (2008) Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 454: 109–13.
Zhou R, Acton P D and Ferrari V A (2006) Imaging stem cells implanted in infarcted myocardium. J Am Coll Cardiol 48: 2094–106.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Netherlands
About this chapter
Cite this chapter
Pesce, M., Pompilio, G., Gambini, E., Capogrossi, M.C. (2011). Cardiac Stem Cells: Tales, Mysteries and Promises in Heart Generation and Regeneration. In: Steinhoff, G. (eds) Regenerative Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9075-1_12
Download citation
DOI: https://doi.org/10.1007/978-90-481-9075-1_12
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9074-4
Online ISBN: 978-90-481-9075-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)